An Adaptive Treatment Strategy for Adolescent Depression
Phase of Trial: Phase I/II
Latest Information Update: 05 Nov 2019
Price : $35 *
At a glance
- Drugs Fluoxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PTAD
- 10 Jun 2016 Status changed from recruiting to completed.
- 15 Mar 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Nov 2016 as per ClinicalTrials.gov record.
- 07 Oct 2015 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov.